Stiefel Laboratories is a specialty pharmaceutical company that focuses on development and commercialization of therapeutics for the dermatology market. It has branded its proprietary foam drug delivery vehicle VersaFoam. The company's marketed products are OLUX foam, 0.05%, Luxiq foam, 0.12%, Soriatane capsules and Evoclin foam, 1%. Stiefel Laboratories is developing Desilux VersaFoam-EF, 0.05%, a low-potency topical steroid formulated to treat atopic dermatitis; Primolux VersaFoam-EF, 0.05%, a high-potency topical steroid formulation to treat atopic dermatitis and plaque psoriasis; Extina VersaFoam-HF, 2%, to treat seborrheic dermatitis and Velac Gel for treating acne. The company s product formulations are designed to improve the management of dermatological diseases and provide significant product differentiation. Its products have earned acceptance by physicians and patients due to clinical effectiveness and cosmetic elegance. Stiefel Laboratories is located in Palo Alto, Calif.